Lecture 8 - Panic Disorder and Agoraphobia Flashcards
1
Q
PD & A - Description (3)
A
- recurrent, unexpected panic attacks, worry and anxiety about having panic attacks, and behaviour is changed to minimise or avoid having panic attacks. Panic attacks are when you feel a sense of dread, choking, shaky, rapid heartrate, wobbly legs and feel faint.
- Prevalence – 2-3% of adults and adolescents, lower in non-Western countries. Low levels in preadolescence, peak is in adulthood (30-60 years), and lower again in older adults. 2:1 gender female to male. Lifetime prevalence of 6.8% in US, 3.5% in Aus.
- Agoraphobia – fear of being in public places. Present not just for people with panic disorder – can be a fear of falling over, getting lost, etc. 1.7% 12 month prevalence. Similar life course. 2:1 gender.
2
Q
PD & A - Aetiology (3)
A
- Clark’s cognitive model of panic – triggering stimulus à perceived threat (out of proportion) à apprehension à body sensations (heart rate, sweating, etc.) à interpretation of these symptoms as catastrophic (confirms the threat). Those without PD don’t have a problem with these sensations in the same way. Anxiety in anticipation of the attack or unrelated heightened anxiety which is interpreted catastrophically. Can happen out of the blue as well
- Rapee model – trigger (external or internal) à physiological change à detection of physiological change à catastrophic attributions à PANIC à anticipation of future panic à attentional allocation to the detection of somatic symptoms, and chronic arousal and hyperalertness.
- Agoraphobia model – avoidance before panic, panic followed by agoraphobia (quickly or slowly). Panic à expectation of future panic à avoid situations in which panic might occur. Not great models for agoraphobia as separate from PD.
3
Q
PD & A - Assessment (4)
A
- clinical interview – detailed description of the most recent attack, list of situations, avoidance, modulators, belief about the panic, and medications.
- Panic Disorder Severity Scale (PDSS) – clinician administered, over the past month, good reliability and validity. Self-report has been developed. 7 items – frequency, distress, severity of anticipation, fear/avoidance of agoraphobic situations and panic sensations, impairment in work/social functioning. 0-4 rating. Remission = <5 or 40% reduction.
- Panic and Agoraphobia Scale (PAS) – clinician/self-report options. Attacks, avoidance, anticipation, disability and functional impairment, and worries. Past week. 0-4 rating. Good reliability and validity. 0-6/8 (in remission), 7/9-17/18 – mild, 18/19-28 – moderate, 29-39 severe, 40+ very severe.
- Self-report – records of panic situations during the week.
4
Q
Diagnosis - PD
A
- recurrent, unexpected panic attacks with 4+ of these symptoms: accelerated heart rate, sweating, trembling and shaking, shortness of breath, choking sensations, chest pain or discomfort, nausea, dizzy/faint, chill/heat sensations, numbness or tingling, depersonalisation/derealisation, fearing losing control/going crazy, fear of dying.
- Panic attacks – an abrupt surge of intense fear that reaches a peak within minutes. Can occur from a calm or anxious state, or nocturnally. These can be used as a specifier for all DSM anxiety disorders since they can occur across all of them.
- Followed by worry or avoidance for at least one month.
5
Q
Diagnosis - Agoraphobia
A
- marked fear or anxiety about 2+ of the following: using public transportation, being in open spaces, being in enclosed spaces, standing in a line or being in a crowd, or being outside of the home alone. Avoids because thoughts that escape might be difficult or help might not be available in these situations if panic symptoms occur.
- Actively avoided, require the presence of a companion or endured with intense anxiety.
- Fear is out of proportion to the actual danger posed, and lasts for 6+ months. Presence of another medical condition (Parkinson’s, enuresis) could make that danger more realistic.
- Separate diagnoses – many with AG do not experience PA. 50% of AG do not have PD, both disorders can precede each other, and AG is associated with non-PD disorders as well (anxiety/mood vs anxiety/mood/substance etc.). AG is more persistent and chronic than PD.
6
Q
DSM5 Changes - PD & A
A
diagnoses are now separate, and consistent with the ICD. Simpler terminology to describe panic attacks, and must have 2+ agoraphobic fears to distinguish from phobias. Time 6+ months rather than none. No requirement for insight that the fear is unreasonable.
7
Q
PD & A - EBT
A
- Medication – pharmacologically decrease the sensitivity of the fear network and reduce the severity and frequency of PA. SSRIs, SNRIs, NRIs, TCAs, MAOIS, BZDs, and other drugs have all shown effects.
- Level 1 evidence for CBT, level 2 evidence for self-help and psychoeducation.
- Exposure is the treatment of choice, relaxation and breathing techniques; medication can have a stronger effect but is poorly tolerated. PMR and interoceptive exposure.
- Psychoeducation – CBT model, identifying negative thoughts. Helping them distinguish between PA symptoms and potential heart attacks.
- Cognitive restructuring – evaluating the accuracy of thoughts and challenging the distorted ones. For/against evidence, alternative explanations.
- Interoceptive exposure – inducing the physical sensations of a panic attack. Need to be frequent and of enough duration that catastrophic thoughts about the sensations are disconfirmed, and the conditioned response is extinguished.
- In vivo exposure for agoraphobia – graded exposure hierarchy.
- Panic attacks in session – stay calm, this too shall pass. Help them to utilise how they would normally manage them outside session. 10 minutes or less usually – give you an opportunity to see how panic attacks are experienced by them. Reassure them and slow breathing.
- Progressive muscle relaxation – lower anxiety and arousal. Help them remember what it feels like to be relaxed. Countering physical symptoms and sensations.
- Additional options – EMDR – recall situation and then clinician takes them through eye movements, emotional regulation therapy, more limited evidence.
- Modalities – individual OR group is better than mixed. AG treated to reduce PD. Duration of disorder and homework.